Caroline Robert

Université Paris XI Sud - Gustave Roussy Cancer Campus

114 Rue Edouard Vaillant

94800 Villejuif

France

SCHOLARLY PAPERS

3

DOWNLOADS

48

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Epacadostat Plus Pembrolizumab versus Placebo Plus Pembrolizumab in Patients with Unresectable or Metastatic Melanoma: Results of the Phase 3, Randomised, Double-Blind Echo-301/Keynote-252 Study

Number of pages: 39 Posted: 05 Feb 2019
The University of Sydney - Melanoma Institute Australia, University Hospital Zurich, Angeles Clinic and Research Institute, University of Chicago - Medical Center, Universidad del Desarrollo - Facultad de Medicina Clínica Alemana, University of Claude Bernard Lyon 1, Hospital Clinic of Barcelona, The University of Sydney - Melanoma Institute Australia, Aix-Marseille University, Seoul National University - Seoul National Hospital, N.N. Blokhin Russian Cancer Research Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Royal Marsden NHS Foundation Trust, Merck & Co., Inc., Incyte Corporation, Incyte Corporation, Merck & Co., Inc. and University of Pennsylvania, Perelman School of Medicine, Abramson Family Cancer Research Institute
Downloads 40 (440,519)

Abstract:

Loading...

melanoma, indoleamine 2,3-dioxygenase, epacadostat, pembrolizumab, immunotherapy

2.

The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors

Number of pages: 43 Posted: 03 Oct 2019
Université Paris XI Sud - Gustave Roussy Cancer Campus, Universite Paris Descartes - Assistance Publique - Hôpitaux de Paris, Hôpital Marie-Lannelongue, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Assistance Publique-Hôpitaux de Paris - Hepato-Biliary Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, University of Paris-Saclay, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpital de Bicêtre, Peupliers Private Hospital, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus and Hôpitaux Universitaires Paris-Sud-Hôpital Bicêtre
Downloads 4 (645,772)

Abstract:

Loading...

Patient care network; Multidisciplinary collaborative approach; Immune-related adverse event; Immune checkpoint inhibitor

3.

Immunological Cytopenia Induced by Anti-Programmed Cell Death (Ligand) 1 Antibodies

Number of pages: 29 Posted: 15 Sep 2018
Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut Universitaire du Cancer, Hôpitaux de Paris (AP-HP) - Hôpital Cochin, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut Universitaire du Cancer, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Lille II - Centre Hospitalier Régional de Lille, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Ambroise Paré Hospital (AP-HP), Université Paris XI Sud - Gustave Roussy Cancer Campus, Institute Jules Bordet - Department of Haematology, Centre Médical de L'Archipel, Les Hôpitaux Universitaires de Strasbourg, Centre Hospitalier Universitaire (CHU) de Bordeaux, Hôpital Morvan Centre Hospitalier Régional Universitaire de Brest, Centre Hospitalier Régional Universitaire Jean Minjoz, Aix Marseille Université - CNRS, INSERM, CIML, Université Paris XI Sud - Gustave Roussy Cancer Campus, Georges Pompidou European Hospital, APHP, Centre Hospitalier de La Rochelle, Hôpital André Mignot, Francis Crick Institute - Haematopoietic Stem Cell Laboratory, Université Paris XI Sud - Gustave Roussy Cancer Campus, Etablissement Français du Sang, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor and Le Commissariat à l’énergie atomique et aux énergies alternatives (CEA)
Downloads 4 (645,772)

Abstract:

Loading...

Immune-related adverse events; Anti-programmed cell death 1; Anti-programmed cell death ligand 1; Neutropenia; Autoimmune hemolytic anemia; Aplastic anemia; Pancytopenia; Immune thrombocytopenia; Pure-red cell aplasia